Search - tctmd.com

Displaying 461 - 480 of 1897

Sort: Relevancy | Date

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Daily News

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

L.A. McKeown

August 12, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

L.A. McKeown

August 03, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

July 30, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

Advertisement

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content